Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0149871 (
deep vein thrombosis
)
12,364
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phlegmasia cerulea dolens
is a rare form of
deep vein thrombosis
. A patient with recurrent episodes of such thrombosis caused by protein C deficiency who developed phlegmasia cerulea dolens is reported. Limb perfusion with urokinase successfully restored venous outflow after unsuccessful attempts at thrombectomy.
...
PMID:Thrombectomy and isolated limb perfusion with urokinase in the treatment of phlegmasia cerulea dolens. 807 98
Phlegmasia cerulea dolens
(
PCD
) is an uncommon, severe form of lower extremity
deep venous thrombosis
characterized by extremity swelling, cyanosis, and pain. Progression of the thrombotic process may result in extremity gangrene, amputation, and death. The relative value of specific therapeutic regimens in the treatment of this disease remains uncertain. Twelve patients, 9 females and 3 males, with
PCD
were treated during a 10-year period. Eighteen lower extremities were involved. Pre-existing conditions included malignancy (eight), postoperative state (four), diabetes (three), previous
deep venous thrombosis
(three), and hypercoagulation (two). Venous gangrene was present in four patients. All patients were treated initially with bedrest, fluid resuscitation, extremity elevation, and systemic high-dose heparin therapy. Five patients had complete resolution with this regimen alone. One patient required cessation of heparin therapy due to heparin-induced thrombocytopenia and developed gangrenous toes. Two patients whose condition failed to respond to heparin therapy underwent catheter-based delivery of urokinase with marked clinical improvement. Four patients, two with venous gangrene, died, three of whom had disseminated malignant disease. A significant percentage of patients with
PCD
will respond to extremity elevation, fluid resuscitation, and aggressive systemic anticoagulation therapy. Thrombolytic therapy selectively administered is beneficial in patients whose disease fails to respond promptly. Venous thrombectomy should be reserved for patients with contraindications to thrombolysis.
...
PMID:Advances in the treatment of phlegmasia cerulea dolens. 835 17
Phlegmasia cerulea dolens
is a potentially devastating complication of extensive
deep venous thrombosis
for which there is currently no consensus for treatment. Heparin anticoagulation, surgical thrombectomy, thrombolytic therapy, fasciotomy, and amputation have each been advocated. We present two cases of phlegmasia cerulea dolens successfully treated with catheter-directed venous thrombolytic therapy.
...
PMID:Catheter-directed thrombolysis in the treatment of phlegmasia cerulea dolens. 973 27
Phlegmasia cerulea dolens
is an uncommon sequela of severe
deep venous thrombosis
of the lower extremities. Characterized by massive edema, arterial and venous compromise, and threats to limb and life, this clinical entity is a clear indication for thrombolytic therapy. We report an innovative approach to conventional thrombolysis via a lesser saphenous vein cut-down. This simple technique is a safe, reliable alternative to present methods of achieving deep venous access. Hence, it should be considered as an addition to the treatment armamentarium for massive
deep venous thrombosis
of the lower extremity.
...
PMID:An alternative approach: antegrade catheter-directed thrombolysis in a case of phlegmasia cerulea dolens. 1007 98
A case of a 71-year-old Japanese woman with toxic shock-like syndrome is reported. She was admitted to the hospital because of swelling of the right leg. On admission, right lower leg was erythematous and swollen with an erosive lesion. On the second day, she rapidly fell into shock.
Phlegmasia cerulea dolens
caused by massive iliofemoral venous thrombosis was suspected because she had a history of
deep venous thrombosis
. But deep venous thrombus was not detected by venography at emergent surgery for thromboembolectomy. She died 38 hours after admission despite maximal supportive therapy. Group A beta-hemolytic streptococci were isolated from blood culture and soft tissue after the patient died.
...
PMID:Toxic shock-like syndrome resembling phlegmasia cerulea dolens. 1048 Mar 9
Phlegmasia caerulea dolens
is a rare complication of a
deep venous thrombosis
and is the result of a massive occlusion of all venous outflow of the extremity. Diagnosis must be made early in the course of the process for treatment effectiveness although it can only produce modest results. The authors analyse retrospectively 3 cases that were treated between 2001 and 2005. The three patients suffered from malignancies (2 from lung and one fom prostate). In all patients a venous thrombectomy was performed and the method employed was described, which includes the systematic use of a caval filter. Two patients coursed with good results, with complete resolution or minor amputation. However, one patient needed an above knee amputation. The authors concluded that the time that mediate to the precise diagnosis and the best option of treatment are important determinations on the results, that however are very dependent on the etiology of this clinical situation.
...
PMID:[Phlegmasia caerulea dolens: therapeutic considerations]. 1589 27
Phlegmasia cerulea dolens
is a limb-threatening form of
deep venous thrombosis
and should be treated aggressively. The authors report a patient who presented with iliocaval and femoral
deep venous thrombosis
and posed an additional therapeutic challenge based on a recent history of heparin-induced thrombocytopenia. Catheter-directed pharmacologic thrombolysis and balloon venoplasty were applied in treatment. The direct thrombin inhibitor argatroban was used in place of heparin for concurrent anticoagulation. This multimodality endovascular approach (chemical and mechanical interventions) was successful in relieving the venous occlusion and salvaging the limb, while maintaining appropriate treatment for heparin-induced thrombocytopenia.
...
PMID:Endoluminal recanalization in a patient with phlegmasia cerulea dolens using a multimodality approach-a case report. 1592 Jun 57
Phlegmasia cerulea dolens
, a rare complication of
deep venous thrombosis
, has traditionally been difficult to treat. The patient described in this report posed additional therapeutic challenges based on a history of heparin-induced thrombocytopenia. She presented with severe leg pain and swelling, and a venogram showed occlusion of both her inferior vena cava and right iliac vein. The use of a multimodality approach, both chemical and mechanical, was successful in removing the venous occlusion, thereby preventing further complications, such as circulatory shock, postphlebitic syndrome, and venous gangrene.
...
PMID:Endoluminal recanalization in a patient with phlegmasia cerulea dolens using a multimodality approach. 1628 9
Phlegmasia cerulea dolens
is an uncommon but potentially life-threatening complication of acute
deep vein thrombosis
. It is an emergency and delay in treatment may cause death or loss of the patient's limb. Surgical thrombectomy is the recommended treatment in venous gangrene. Catheter-directed intrathrombus thrombolysis has been reported as successful, but it may require a lengthy infusion. Manual aspiration thrombectomy may clear the entire thrombus with no need for thrombolytic administration and provide rapid and effective treatment for patients with phlegmasia cerulea dolens with impending venous gangrene.
...
PMID:Manual aspiration thrombectomy with stent placement: rapid and effective treatment for phlegmasia cerulea dolens with impending venous gangrene. 1771 Apr 67
Phlegmasia cerulea dolens
is an extreme form of
deep venous thrombosis
with a proximal localization of the blockage, most frequently in the ileofemoral area. Symptoms are graded as follows: swelling of the entire extremity, pain, and cyanosis. This form of the disease is rare, occurring most frequently in the terminal stage of malignancies. Diagnosis of phlegmasia usually causes no problems because the proper diagnosis is usually revealed during clinical examination and confirmed by imaging techniques. The authors present a case report of phlegmasia cerulean dolens and discuss the options for treatment.
...
PMID:Phlegmasia cerulea dolens as a complication of a severe form of acute hemorrhagic-necrotizing pancreatitis. 1818 Jun 25
1
2
3
Next >>